Geode Capital Management’s Alpha Tau Medical DRTS Stock Holding History

Geode Capital Management’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$672K	Hold	53,399	–	–	﹤0.01%	3490
2026 Q1	$378K	Buy	53,399 +15,506	+41%	+$109K	﹤0.01%	3687
2025 Q4	$188K	Hold	37,893	–	–	﹤0.01%	3926
2025 Q3	$171K	Hold	37,893	–	–	﹤0.01%	3974
2025 Q2	$118K	Hold	37,893	–	–	﹤0.01%	4018
2025 Q1	$95.1K	Hold	37,893	–	–	﹤0.01%	4043
2024 Q4	$117K	Buy	37,893 +2,177	+6%	+$5.57K	﹤0.01%	4058
2024 Q3	$85K	Hold	35,716	–	–	﹤0.01%	4150
2024 Q2	$90.4K	Hold	35,716	–	–	﹤0.01%	4162
2024 Q1	$105K	Hold	35,716	–	–	﹤0.01%	4146
2023 Q4	$108K	Hold	35,716	–	–	﹤0.01%	4169
2023 Q3	$135K	Buy	35,716 +2,640	+8%	+$9.67K	﹤0.01%	4141
2023 Q2	$145K	Buy	33,076 +6,470	+24%	+$23.2K	﹤0.01%	4187
2023 Q1	$76.4K	Buy	26,606 +6,364	+31%	+$22.2K	﹤0.01%	4424
2022 Q4	$64K	Hold	20,242	–	–	﹤0.01%	4522
2022 Q3	$118K	Hold	20,242	–	–	﹤0.01%	4495
2022 Q2	$182K	Buy	+20,242	New	+$181K	﹤0.01%	4324

Other funds holding DRTS

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Geode Capital Management's DRTS Position: Q2 2026 in Review

Geode Capital Management held its Alpha Tau Medical (DRTS) position steady in Q2 2026 at 53,399 shares worth $672K. The position accounts for ﹤0.01% of the portfolio, ranked #3490.

Geode Capital Management first reported a position in DRTS in Q2 2022 and has held it in 17 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

Geode Capital Management held 53,399 shares of Alpha Tau Medical worth $672K as of Q2 2026.
Geode Capital Management left its Alpha Tau Medical share count unchanged in Q2 2026.
Alpha Tau Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3490 holding.
Geode Capital Management first reported a position in Alpha Tau Medical in Q2 2022 and has held it in 17 quarters since.
74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.